Home » Topics » Conferences

Conferences
RSS

Antitumor combretastatin A4 derivative reported by Ajinomoto

April 14, 1998

Antiangiogenic ribozyme from Ribozyme and Chiron presented at cancer meeting

April 14, 1998

New bFGF-TK inhibitor from Parke-Davis

April 14, 1998

Novel ECE inhibitor isolated from Streptomyces

April 14, 1998

Taisho's rugatocenones inhibit cell adhesion

April 14, 1998

Novartis presents new tyrosine kinase inhibitor with antiresorptive activity

April 14, 1998

Aplidine evaluated for activity in animal models of lymphoma, prostate and gastric cancer

April 9, 1998

Mechanism of cytotoxic effect of ImmTher

April 9, 1998

PKCbeta inhibitor from Lilly may potentiate effects of radio- and chemotherapy

April 9, 1998

New cell therapy developed at Wistar Institute shows potential as chemotherapy adjuvant

April 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...